Figure 4.
![Figure 4. Comparative activities of A24, AZT, IFN-α, VP16, and Ars on the proliferation of tumor cells. Tumor cells from a patient with chronic ATL were incubated with or without A24 and treated with or without different chemotherapeutic agents such as AZT, IFN-α, or both AZT and IFN-α, Ars, or VP16 for 72 hours to determine the potential synergistic effect of these agents with A24. Cells were pulsed with [3H]-thymidine and harvested, before measuring the incorporation of [3H]-thymidine. Data are means ± SD of one representative experiment of 3 separate experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/103/5/10.1182_blood-2003-07-2440/6/zh80050457650004.jpeg?Expires=1722411873&Signature=soW6aLoQ~BkNwcOMePCAuV1KCROn9g3FmKobdRyFd0FM6ngbQla-yEj0A7-jNR7t1SnSdUqtr4f8BOOs6kvmXctiIsMvJZwMfgxGOS6xy2v~37k7yxV7fJiWX1P57siLH3gCPtC3171cyYo3KOvGge4Pm7G16~eIuIGr9xW4fsxB-CR8UTOFCunyHyzamLQttW2NBppVqWGp~3fk-aLtfLdFufU5jUerenQfiue5DFyDdH6huwNR2U4fsyTK6O6Gs8Aj5CrtHZo68Fdp3iTEKsqZEk3Mwdi9504RG2WXQ13jZd6U4eyy8k5YN8AKSSnZ-2IcRdqQhinudfvLxIJhUw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparative activities of A24, AZT, IFN-α, VP16, and Ars on the proliferation of tumor cells. Tumor cells from a patient with chronic ATL were incubated with or without A24 and treated with or without different chemotherapeutic agents such as AZT, IFN-α, or both AZT and IFN-α, Ars, or VP16 for 72 hours to determine the potential synergistic effect of these agents with A24. Cells were pulsed with [3H]-thymidine and harvested, before measuring the incorporation of [3H]-thymidine. Data are means ± SD of one representative experiment of 3 separate experiments.
